Newsletter

Subscribe and recieve updates on this company.

Text STOCKS to 72727 for mobile alerts

We are excited to present Cardiovascular Systems, Inc. (NASDAQ: CSII).

Full DD Report for CSII

You must become a subscriber to view this report.


Recent News from (NASDAQ: CSII)

Cardiovascular Systems' (CSII) CEO Scott Ward on Q3 2018 Results - Earnings Call Transcript
Cardiovascular Systems, Inc. (CSII) Q3 2018 Results Earnings Conference Call May 02, 2018, 04:45 PM ET Executives Jack Nielsen - Senior Director of Corporate Communications & IR Jeffrey Points - CFO Rhonda Robb - COO Scott Ward - Chairman, CEO and President Analysts B...
Source: SeekingAlpha
Date: May, 02 2018 20:36
Cardiovascular Systems, Inc. Reports Fiscal 2018 Third-Quarter Financial Results
Conference Call Scheduled for Today, May 2, 2018, at 3:45 PM CT (4:45 PM ET) Revenues of $55.6 million increased 7% from third quarter last year Net income was $0.4 million, or $0.01 per basic and diluted share First patients treated from radial access using Diamondback 3...
Source: Business Wire
Date: May, 02 2018 16:05
Research Report Identifies Spartan Motors, Cardiovascular, Stone Energy, Verisk Analytics, National Bank, and Sonoco Products with Renewed Outlook - Fundamental Analysis, Calculating Forward Movement
NEW YORK, April 24, 2018 (GLOBE NEWSWIRE) -- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Spartan Motors, Inc. (NASDAQ:SPAR), Cardiovascular Systems, Inc. (NASDAQ...
Source: GlobeNewswire
Date: April, 24 2018 07:55
Cardiovascular Systems, Inc. to Webcast Fiscal 2018 Third-Quarter Earnings Conference Call Wednesday, May 2
Live Webcast at 3:45 p.m. CT (4:45 p.m. ET) Cardiovascular Systems, Inc. (CSI ® ) (NASDAQ: CSII) will host a live webcast of its fiscal 2018 third-quarter conference call on Wednesday, May 2, 2018, at 3:45 p.m. CT (4:45 p.m. ET). CSI management will discuss results for its fisc...
Source: Business Wire
Date: April, 11 2018 16:05
Cardiovascular Systems (CSII) Presents At Barclays Global Healthcare Conference 2018 - Slideshow
The following slide deck was published by Cardiovascular Systems, Inc. in conjunction with this Read more ...
Source: SeekingAlpha
Date: March, 13 2018 13:05
Cardiovascular Systems Presents LIBERTY 360° 18-Month Outcomes at CRT18 Interventional Cardiology Conference
Results show significant improvements in quality of life and high freedom from major amputation Cardiovascular Systems, Inc. (CSI ® ) (NASDAQ: CSII) a medical device company developing and commercializing innovative interventional treatment systems for patients with periphera...
Source: Business Wire
Date: March, 06 2018 16:05
Cardiovascular Systems, Inc. and OrbusNeich Announce FDA Clearance of the First and Only 1.0mm Coronary Balloon in the U.S.
Device is the smallest, 510(k) cleared coronary balloon in the U.S. market Cardiovascular Systems, Inc. (CSI ® ) (NASDAQ: CSII), a medical device company developing and commercializing innovative interventional treatment systems for patients with peripheral and coronary artery ...
Source: Business Wire
Date: March, 01 2018 14:31
Report: Developing Opportunities within Main Street Capital, United States Cellular, FibroGen, Cardiovascular, CDW, and ANSYS - Future Expectations, Projections Moving into 2018
NEW YORK, March 01, 2018 (GLOBE NEWSWIRE) -- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Main Street Capital Corporation (NYSE:MAIN), United States Cellular Corp...
Source: GlobeNewswire
Date: March, 01 2018 07:55
Cardiovascular Systems (CSII) Presents At Leerink Partners 7th Annual Global Healthcare Conference - Slideshow
The following slide deck was published by Cardiovascular Systems, Inc. in conjunction with this Read more ...
Source: SeekingAlpha
Date: February, 15 2018 13:20
Cardiovascular Systems, Inc. Announces First Patients Treated from Radial Access Using Its Diamondback 360® Extended Length Peripheral Orbital Atherectomy Device
Device provides alternative access point to treat patients suffering from peripheral artery disease Cardiovascular Systems, Inc. (CSI ® ) (NASDAQ: CSII), a medical device company developing and commercializing innovative interventional treatment systems for peripheral and coron...
Source: Business Wire
Date: February, 14 2018 07:00

 


Last 5 Days Trading Activity

DateOpen PriceClose PriceHighLowVolume
2018-08-2137.6038.0338.2037.59148,302
2018-08-2037.5037.6037.7637.11116,970
2018-08-1737.4437.5637.8537.38179,071
2018-08-1637.4437.5237.70536.91178,547
2018-08-1537.0437.3937.824636.895164,882

Last 5 Days Short Activity

DateShort VolumeTotal VolumeShort PercentageShort Indicator
2018-08-2118,07456,74131.8535Cover
2018-08-209,31534,26527.1852Cover
2018-08-1717,59955,42831.7511Cover
2018-08-1632,90670,26446.8319Short
2018-08-1525,31241,88660.4307Short

* Cover Mode

Short Analysis provided by Squeeze Report. Get a complete short report on CSII.


About Cardiovascular Systems, Inc. (NASDAQ: CSII)

Logo for Cardiovascular Systems, Inc. (NASDAQ: CSII)

Not available

 

Contact Information

 

 

Current Share Structure

  • Market Cap: $966,651,803 - 05/15/2018
  • Issue and Outstanding: 33,218,275 - 02/02/2018

 


Recent Filings from (NASDAQ: CSII)

Quarterly report with a continuing view of a company's financial position
Filing Type: 10-QFiling Source: edgar
Filing Date: May, 04 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: May, 02 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: March, 29 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: March, 16 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: March, 02 2018
Amendment to the SC 13G filing
Filing Type: SC 13G/AFiling Source: edgar
Filing Date: February, 21 2018
Amendment to the SC 13G filing
Filing Type: SC 13G/AFiling Source: edgar
Filing Date: February, 14 2018
Amendment to the SC 13G filing
Filing Type: SC 13G/AFiling Source: edgar
Filing Date: February, 14 2018
Amendment to the SC 13G filing
Filing Type: SC 13G/AFiling Source: edgar
Filing Date: February, 13 2018
Filing Type: CT ORDERFiling Source: edgar
Filing Date: February, 13 2018

 

 


Daily Technical Chart for (NASDAQ: CSII)

Daily Technical Chart for (NASDAQ: CSII)


Stay tuned for daily updates and more on (NASDAQ: CSII)

It most certainly could but even more important is the recent overwhelming interest in the company. Check out Investors Hub and search on Twitter

More to come on (NASDAQ: CSII)

Do your DD and if you choose, be ready to go!


 

The Research: All source information contained in this email is from the public sources mentioned below.

 

 
 

Thank you

DD Report
@DDReports

 

 


Disclaimer: DD Report publishes reports providing information on selected companies. DD Report is not a registered investment advisor or broker-dealer. This report is provided as an information service only, and the statements and opinions in this report should not be construed as an offer or solicitation to buy or sell any security. DD Report accepts no liability for any loss arising from an investors reliance on or use of this report. An investment in CSII is considered to be highly speculative and should not be considered unless a person can afford a complete loss of investment. DD Report has received up to $100,000 worth of crypto currency from a non-affiliated third party for the publication and circulation of this report. DD Report does not own any shares of CSII and does not buy, sell, or trade any shares of CSII. This report contains forward-looking statements, which involve risks, and uncertainties that may cause actual results to differ materially from those set forth in the forward-looking statements. Copyright 2018 by DD Report. All rights reserved. Our Full Disclaimer: http://dd.report/disclaimer/